FDA to Further Study Deceptive Drug Advertising

0 Flares Twitter 0 Facebook 0 Google+ 0 LinkedIn 0 Email -- 0 Flares ×

FDA to Further Study Deceptive Drug Advertising

By Michael Mezher

The US Food and Drug Administration (FDA) says it plans to study how well consumers and healthcare professionals are able to identify deceptive or misleading information in drug advertisements.

While FDA says there have been a number of studies in the past looking into the occurrence and influence of deceptive advertising, there hasn't been research into how well consumers and healthcare professionals are able to identify deceptive drug promotion.

“The ability to identify such promotion has important public health implications,” FDA says.

On one hand, misled consumers might ask their doctors to prescribe drugs they might not need, and on the other, physicians that fail to recognize the deceptive information might end up prescribing them.

According to FDA, how well consumers and healthcare professionals are able to identify deceptive information plays a role in the agency's enforcement efforts.

“Reports of deceptive promotion are useful to FDA because they allow investigators to focus their efforts in an era where the amount of promotion far exceeds the resources available to monitor everything,” FDA says.


FDA says it plans to conduct two studies, each designed to answer different questions, each of which will include patients and physician populations.

To conduct the studies, FDA says it plans to contract with a firm to develop “mock” websites that will appear similar to actual prescription drug websites. According to the agency, the sites shown to patients and physicians will be mostly identical, with pages geared towards physicians including more statistical information and medical terminology.

In both studies, FDA says it also plans to measure participants' intent to report deceptive information based on the degree and type of deception present in the promotional pieces.

The announcement of the study follows a number of recent proposals to evaluate such marketing practices, including a study on whether consumers can take more complicated information in television ads, how the public understands drug risks and more. Drugmakers have been critical of such research in the past.

Read full article and learn more about Deceptive Advertising here.

Here’s How To Make Sure You,
Your Business & Website Is FTC Compliant

By now it should be clear how important it is for you to be FTC compliant. But how can you do that without spending $7,500-$8,000 or more on Internet Attorneys?

Smart business owners around the world are doing it with the help of FTC Guardian.

FTC Guardian is a service that is 100% focused on helping to keep you get and stay FTC compliant and fully protected. And right now, we are offering a free training to give you the knowledge, information, and guidance that you need to stay out of trouble with the Federal Trade Commission.

The training is titled: 3 Tragic (Legal) Privacy Policy List Building Mistakes That Can Get You In Hot Water With The FTC Today – Resulting In Your Business Being Shut Down… And How To Solve It!

Here are some of the things you’ll discover on the training:

  • Real-Life Examples of People Who Didn’t Think They Were At Risk, But Who Got Nailed By The FTC, And Why It Could Happen To You, Too
  • Why 2014 Was a Significant Year For Online Businesses, And Why You Should Be Worried!
  • The 3 Enormous Powers The FTC Has That Can Change Your Life – And Your Family’s Life – Forever!
  • How to Avoid FTC Claims When Collecting Leads With Optin Forms
  • 3 Privacy Policy Mistakes Every Digital Marketer Is Making, And Why You're In The FTC Crosshairs.
  • And Much More…

Remember: legal protection is a massively important part of your business, and it’s one you cannot afford to ignore any longer.

Go here to register for our next FREE training and make your business is FTC compliant today!

Disclaimer:  This article is provided for informational purposes only. It’s not legal advice, and no attorney-client relationship is created. Neither the author nor FTC Guardian, Inc. is endorsed by the Federal Trade Commission.

0 Flares Twitter 0 Facebook 0 Google+ 0 LinkedIn 0 Email -- 0 Flares ×